Perioperative Use of Gabapentin To Decrease Narcotic Requirements in Spinal Fusion
NCT ID: NCT00726999
Last Updated: 2019-04-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2006-06-30
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Postoperative Analgesia of Gabapentin Plus Nefopam in the Spinal Surgery
NCT04491786
Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion
NCT04095624
Multidisciplinary Perioperative Care Pathway in Adolescents Undergoing Posterior Spinal Fusion Surgery
NCT04038229
Combination of Preoperative Gabapentin and TAP Blocks in Decreasing Postoperative Pain
NCT02927405
Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management
NCT02605187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Blinded, drug only known by hospital pharmacist. Study group 1- Gabapentin 15mg/kg with premed, 5/kg TID for 5 days of discharge, standard PCA morphine with dose and basal Study Group 2- Capsules resembling neurontin, with standard PCA morphine
No remifentanil, clonidine, ketamine
N=60 First patient enrolled 6/06 Last patient enrolled 7/15/08
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Gabapentin
Gabapentin
oral gabapentin in load pre-op (15mg/kg) and maintenance 5mg/kg TID for 5 days or discharge
Morphine
Administered as needed
2
Placebo Comparator -- pill matched in appearance to gabapentin
Placebo
Morphine
Administered as needed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gabapentin
oral gabapentin in load pre-op (15mg/kg) and maintenance 5mg/kg TID for 5 days or discharge
Placebo
Morphine
Administered as needed
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Neuromuscular scoliosis
* On narcotics baseline
9 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital and Health System Foundation, Wisconsin
OTHER
Medical College of Wisconsin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lynn Rusy
Professor of Anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lynn M Rusy, MD
Role: PRINCIPAL_INVESTIGATOR
Medical College of Wisconsin
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06/71,GC 138
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.